COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was declared a global pandemic by the World Health Organization (WHO). The clinical course of the disease is unpredictable but may lead to severe acute respiratory infection (SARI) and pneumonia leading to acute respiratory dist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceuticals (Basel)
Autors principals: Kotfis, Katarzyna, Lechowicz, Kacper, Drożdżal, Sylwester, Niedźwiedzka-Rystwej, Paulina, Wojdacz, Tomasz K., Grywalska, Ewelina, Biernawska, Jowita, Wiśniewska, Magda, Parczewski, Miłosz
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830835/
https://ncbi.nlm.nih.gov/pubmed/33477294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010071
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars